Drusolv Therapeutics, Inc.

Pharmaceutical company · Philadelphia, Pennsylvania, United States

Drusolv Therapeutics, Inc. is a pharmaceutical company headquartered in Philadelphia, Pennsylvania, United States. Its earliest recorded incorporation is in 2017. It has reported private securities offerings to the US SEC, most recently $500,000 sold in a notice filed in 2022.

Profile compiled from public records. Is this your company? Request a correction or update

Drusolv Therapeutics at a glance

Typepharmaceutical company

HeadquartersPhiladelphia, Pennsylvania, United States

Earliest incorporation on record2017

SEC CIK1923102

What does Drusolv Therapeutics do?

Private fundraising reported to the SEC

1 Form D notice; the most recent reported $500,000 sold (2022).

Frequently asked questions about Drusolv Therapeutics

Where is Drusolv Therapeutics headquartered?

Drusolv Therapeutics, Inc. is headquartered in Philadelphia, Pennsylvania, United States.

What does Drusolv Therapeutics do?

Drusolv Therapeutics, Inc. is a pharmaceutical company.

When was Drusolv Therapeutics founded?

The earliest incorporation on record for Drusolv Therapeutics, Inc. is in 2017, according to public company registers.

Similar companies

Context Therapeutics Inc.Philadelphia, Pennsylvania, United States
Lannett Co IncPhiladelphia, Pennsylvania, United States
Carisma Therapeutics Inc.Philadelphia, Pennsylvania, United States
Avid Radiopharmaceuticals, Inc.Philadelphia, Pennsylvania, United States
EpiVario Inc.Philadelphia, Pennsylvania, United States
Verismo Therapeutics, Inc.Philadelphia, Pennsylvania, United States
Aro Biotherapeutics CoPhiladelphia, Pennsylvania, United States
Alveus Therapeutics, Inc.Philadelphia, Pennsylvania, United States

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences